AI Drug Discovery Just Hit Escape Velocity: Roche, Google, and a $7.2B Deal

Very Bullish

What Happened

In a single week, Roche announced AI-driven drug discovery independence, Google DeepMind launched a generative enzyme design system, and Abogen inked a $7.2B RNA therapeutics deal with Novartis.

Bottom Line

The AI drug discovery revolution is accelerating, with major players achieving key milestones that could unlock massive value in the biotech sector.

Free preview — more China A-share & HK research · About Us · Legal & Privacy